AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,762 | +24.6% | 3,300 | 0.0% | 0.00% | – |
| Q2 2023 | $3,020 | +63.3% | 3,300 | 0.0% | 0.00% | – |
| Q1 2023 | $1,849 | -2.9% | 3,300 | 0.0% | 0.00% | – |
| Q4 2022 | $1,904 | +90.4% | 3,300 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 3,300 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 3,300 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -71.4% | 3,300 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -30.0% | 3,300 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | -23.1% | 3,300 | 0.0% | 0.00% | – |
| Q2 2021 | $13,000 | +18.2% | 3,300 | 0.0% | 0.00% | – |
| Q1 2021 | $11,000 | +22.2% | 3,300 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | +12.5% | 3,300 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | -82.2% | 3,300 | 0.0% | 0.00% | – |
| Q2 2020 | $45,000 | -10.0% | 3,300 | -50.0% | 0.00% | – |
| Q1 2020 | $50,000 | +19.0% | 6,600 | 0.0% | 0.00% | – |
| Q4 2019 | $42,000 | +61.5% | 6,600 | 0.0% | 0.00% | – |
| Q3 2019 | $26,000 | -18.8% | 6,600 | 0.0% | 0.00% | – |
| Q2 2019 | $32,000 | -40.7% | 6,600 | 0.0% | 0.00% | – |
| Q1 2019 | $54,000 | +50.0% | 6,600 | 0.0% | 0.00% | – |
| Q4 2018 | $36,000 | -37.9% | 6,600 | 0.0% | 0.00% | – |
| Q3 2018 | $58,000 | -12.1% | 6,600 | 0.0% | 0.00% | – |
| Q2 2018 | $66,000 | +4.8% | 6,600 | 0.0% | 0.00% | – |
| Q1 2018 | $63,000 | -35.7% | 6,600 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $98,000 | -24.6% | 6,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $130,000 | +36.8% | 6,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $95,000 | +55.7% | 6,600 | 0.0% | 0.00% | – |
| Q1 2017 | $61,000 | -11.6% | 6,600 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $69,000 | +15.0% | 6,600 | 0.0% | 0.00% | – |
| Q3 2016 | $60,000 | +22.4% | 6,600 | 0.0% | 0.00% | – |
| Q2 2016 | $49,000 | -16.9% | 6,600 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $59,000 | -30.6% | 6,600 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $85,000 | +32.8% | 6,600 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $64,000 | -5.9% | 6,600 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $68,000 | +19.3% | 6,600 | +29.4% | 0.00% | – |
| Q1 2015 | $57,000 | +14.0% | 5,100 | +17.9% | 0.00% | – |
| Q4 2014 | $50,000 | -47.9% | 4,326 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $96,000 | +88.2% | 4,326 | +136.9% | 0.00% | – |
| Q2 2014 | $51,000 | – | 1,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |